3.57
0.16 (4.69%)
0.16 (4.69%)
Upgrade to Real-Time
Afterhours (Closed)
Low
0.81
High
9.80
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Atossa Therapeutics Inc | ATOS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.16 | 4.69% | 3.57 | 19:58:26 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.41 | 3.3101 | 3.57 | 3.58 | 3.41 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.56 | 3.57 | 0.01 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 21,427 | 9,040,318 | $ 3.44 | $ 31,087,522 | - | 0.81 - 9.80 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:58:26 | formt | 500 | $ 3.57 | USD |
Period:
Draw Mode:
Atossa Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 452.05M | 126.62M | 126.57M | $ - | $ - | -1.97 | -2.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -164.58k | 0.40% |
Atossa Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATOS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.65 | 4.11 | 3.19 | 3.56 | 7,810,972 | -0.08 | -2.19% |
| 1 Month | 3.19 | 4.3101 | 3.17 | 3.64 | 6,980,592 | 0.38 | 11.91% |
| 3 Months | 8.05 | 9.80 | 2.75 | 5.15 | 14,230,151 | -4.48 | -55.65% |
| 6 Months | 2.64 | 9.80 | 1.48 | 4.53 | 14,574,134 | 0.93 | 35.23% |
| 1 Year | 2.39 | 9.80 | 0.81 | 3.58 | 13,527,295 | 1.18 | 49.37% |
| 3 Years | 1.68 | 9.80 | 0.755 | 3.59 | 5,046,839 | 1.89 | 112.5% |
| 5 Years | 24.60 | 31.20 | 0.755 | 4.25 | 3,629,776 | -21.03 | -85.49% |
Atossa Therapeutics Description
| Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in the US. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use. |
